SCHEMBL8349430

SCHEMBL8349430

CCCOc1cc2c(Nc3cccc(Br)c3)ncnc2cc1OC

nearest known ligand 0.91

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 11/20 0.91
▸ FBP1 P09467 3/20 0.86
▸ KDR P35968 9/20 0.85
▸ ERBB2 P04626 4/20 0.85
▸ SRC P12931 2/20 0.85
▸ KDM4E B2RXH2 1/20 0.85
▸ GAK O14976 1/20 0.85
▸ MAPK13 O15264 1/20 0.85
▸ ABL1 P00519 1/20 0.85
▸ CYP1A2 P05177 1/20 0.85
▸ CDK1 P06493 1/20 0.85
▸ CYP3A4 P08684 1/20 0.85
▸ CYP2D6 P10635 1/20 0.85
▸ MAPT P10636 1/20 0.85
▸ CYP2C9 P11712 1/20 0.85
▸ TSHR P16473 1/20 0.85
▸ MAPK1 P28482 1/20 0.85
▸ EPHB2 P29323 1/20 0.85
▸ CYP2C19 P33261 1/20 0.85
▸ MAPK12 P53778 1/20 0.85

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5742396 0.94 EGFR (0.86) EGFRFBP1KDRERBB2SRC
SCHEMBL22367416 0.93 FBP1 (1.00) EGFRFBP1KDRERBB2SRC
SCHEMBL4232360 0.93 FBP1 (0.84) EGFRFBP1KDRERBB2SRC
SCHEMBL12963484 0.92 FBP1 (0.91) EGFRFBP1KDRERBB2SRC
SCHEMBL29444884 0.92 EGFR (1.00) EGFRFBP1KDRERBB2SRC
SCHEMBL9423 0.92 EGFR (1.00) EGFRFBP1KDRERBB2SRC
SCHEMBL30363011 0.92 EGFR (1.00) EGFRFBP1KDRERBB2SRC
SCHEMBL28641557 0.92 FBP1 (0.83) EGFRFBP1KDRERBB2SRC
Hydrochloric Acid SCHEMBL29369196 0.91 EGFR (1.00) EGFRFBP1KDRERBB2SRC
Hydrochloric Acid SCHEMBL30362813 0.91 EGFR (1.00) EGFRFBP1KDRERBB2SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003024448-A2 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE, INC. (CA) 2003-03-27 — — WO disclosed
Send feedback